IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 198 filers reported holding IMPAX LABORATORIES INC in Q1 2015. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $607,000 | +7.2% | 29,900 | -30.0% | 0.02% | +15.0% |
| Q4 2016 | $566,000 | -54.6% | 42,700 | -1.4% | 0.02% | -52.4% |
| Q2 2016 | $1,248,000 | +78.0% | 43,300 | +97.7% | 0.04% | +100.0% |
| Q1 2016 | $701,000 | +38.3% | 21,900 | +36.9% | 0.02% | +16.7% |
| Q4 2014 | $507,000 | -15.8% | 16,000 | -45.6% | 0.02% | -67.3% |
| Q3 2013 | $602,000 | -19.9% | 29,400 | -22.0% | 0.06% | -28.6% |
| Q2 2013 | $752,000 | – | 37,700 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 423,161 | $13,406,000 | 7.47% |
| Aravt Global | 2,300,000 | $72,864,000 | 5.43% |
| Slate Path Capital LP | 2,330,000 | $73,814,000 | 5.16% |
| Orbimed Advisors | 6,678,000 | $211,559,000 | 2.02% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Penn Capital Management Company, LLC | 709,045 | $22,463,000 | 0.94% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $7,920,000 | 0.79% |
| NEW AMSTERDAM PARTNERS LLC/NY | 276,169 | $8,749,000 | 0.76% |
| Matarin Capital Management, LLC | 52,932 | $1,676,886,000 | 0.74% |